Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $13.8750 (-3.07%) ($13.3200 - $14.4800) on Thu. Nov. 5, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.65% (three month average) | RSI | 49 | Latest Price | $13.8750(-3.07%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA advances 0.5% a day on average for past five trading days. | Weekly Trend | ATRA declines -2.2% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(53%) ARKG(45%) IBB(45%) ARKK(44%) IWO(43%) | Factors Impacting ATRA price | ATRA will decline at least -1.825% in a week (0% probabilities). VIXM(-32%) VXX(-26%) UNG(-11%) UUP(-8%) TLT(-6%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.825% (StdDev 3.65%) | Hourly BBV | 0.7 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $5.75(-58.56%) | Resistance Level | $13.91 | 5 Day Moving Average | $13.38(3.7%) | 10 Day Moving Average | $13.69(1.35%) | 20 Day Moving Average | $13.91(-0.25%) | To recent high | -12.6% | To recent low | 16.4% | Market Cap | $1.031b | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |